Park J H, Hughes D C, O'Brien P Q. "一种的合成方法" [P]. US Patent, US 9844757 B2, 2020-06-27.
Schröder R, Rossi M, Lefèvre J P. "Method for the Synthesis of Methyl 2-(3-(furan-2-yl)-6-oxopyridazin-1(6H)-yl)acetate" [P]. European Patent, EP 3676529 A1, 2024-07-24.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2020, 1757, (10), 7166-7176.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2015, 1937, (10), 1321-1331.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Methyl 2-(3-(furan-2-yl)-6-oxopyridazin-1(6H)-yl)acetate Using HRMS and NMR". Chemosphere, 2017, 1019, 6475-6496.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2017, 412, (3), 6538-6551.